
Private equity owns your roadmap — should you stay?
hinking of leaving a private equity-owned company? Brian de Haaff examines how an owner's investment timeline can affect product builders — and how to understand their priorities.
Improve customer feedback with Elle, the AI assistant in Aha! software. Help customers describe their ideas clearly with AI validation and automatically suggest the…
Compare Aha! Roadmaps vs. Atlassian's Jira Product Discovery and Jira for enterprise product management. See differences in strategy, planning, customer feedback, AI…
Aha! Discovery now helps you recruit research participants directly inside your application. Find active users, review their responses, and send interview invites.
Receive tips on building lovable products — delivered to your inbox.
Explore how AI impacts product management — from streamlining research and prioritization to enhancing decision-making and customer insights.
Gain the insights and tools you need to manage products effectively. Build confidence in your decisions and consistently deliver value.
Uncensored advice about product development and building a high-growth software company from Brian de Haaff, co-founder and CEO at Aha!
Our team values integrity, ambition, effort, skill, and team spirit. Read the stories about why we joined Aha! — and why you should too.

Aha! software updates from Q3 2026 help you bring customer insights into product decisions, automate repeatable tasks, and compare AI-generated prototypes.

Introducing the Aha! desktop app for Mac and Windows. It is a focused space to work with Elle (the AI assistant), review to-dos, and update product records.

See the applications that won AI Builder Day, from a satellite-powered environmental alert tool to an EV charging assistant.

Compare Aha! Builder and v0 to find the right AI app builder for your team. Get details on key use cases, workflows, and pricing.

Customize Aha! Builder security and privacy reviews with documented exceptions — so findings reflect your organization's policies, accepted risks, and known limitations.